In the clinical situation, the diagnosis and prognosis are based on the histopathological grading by using the Gleason score, measurement of the prostate specific antigen (PSA) in blood and clinical staging of prostate cancer (Falzarano et al., 2015; Partin et al., 2002). This evidence concerns the gene KLK3 and prostate carcinoma.